FAE Faes Farma, S.A.
4.600EUR+1.55%Mkt Cap: 1.56B $P/E: 17.04Today
Faes Farma, S.A., researches, develops, produces, and markets pharmaceutical products, healthcare products, and raw materials internationally. The company operates through Pharmaceutical and Healthcare Specialties; Anima…
Industry Peers
Drug Manufacturers - Specialty & Generic$64.30BUSDP/E 25.0
$57.06BUSD
$46.10BUSDP/E 65.9
$38.70BUSDP/E 18.3
$28.27BUSDP/E 12.1
$28.80BUSDP/E 11.4
$23.23BUSDP/E 19.4
$20.22BUSD
$14.24BUSDP/E 109.4
$14.55BUSDP/E 21.0
$12.60BUSDP/E 22.8
$11.06BUSD
$10.20BUSDP/E 29.2
$8.50BUSDP/E 18.4
$7.07BUSDP/E 42.3
$7.00BUSDP/E 109.9
$6.77BUSD
$6.53BUSDP/E 23.9
$5.83BUSDP/E 76.6
$4.21BUSDP/E 12.8
| Headline | Source | Time |
|---|---|---|
Older | ||
 Faes Farma (BME:FAE) Following Strong Half Year Earnings Still Looks Undervalued Faes Farma (BME:FAE) has drawn fresh attention after reporting half year 2026 earnings, with sales of €382.9 million and net income of €56.88 million compared with the same period a year earlier. See our latest analysis for Faes Farma. The recent half year earnings come after a period where Faes Farma’s share price has softened, with the year-to-date share price return down 13.12%, while the 1-year total shareholder return is 9.83% and the 5-year total shareholder return is 66.35%. If you are... | ||
EEl Correo | ||